Supported By Experts

Dr Edna Venneker

“From my analysis of clinical and translational data, capsaicin remains one of the most compelling pain therapeutics. By selectively targeting TRPV1-positive sensory nerve fibres, it can provide prolonged analgesia while minimising systemic side effects.”

Former Head of Development and Senior Vice President at Grünenthal

Professor David Hunter

“Based on my analysis of the clinical trial data on Capsaicin for Knee OA pain, I think the RM-010 program is definitely worth pursuing.”

The logo of the University of Sydney, featuring a shield with various symbols and the text 'The University of Sydney'
Black and white portrait of a smiling man wearing a suit jacket and collared shirt.

Dr Nathaniel Katz

“Capsaicin has proven effective across pain indications, including positive studies in Knee OA, as well as a good safety profile, making this a promising analgesic.”

WCG logo with stylized 'W' and 'V' above the text.
Black and white portrait of a man with curly hair and a beard, wearing a blazer and a T-shirt.

Dr Diana Meske

“Based on the clinical data, I have no doubt that Capsaicin is an effective analgesic for Knee OA pain with an extremely clean safety profile.”

Former Clinical Director

Logo for Centrexion Therapeutics featuring the company name with a circular emblem with radiating lines.
A woman with shoulder-length curly hair smiling, wearing a floral blouse and a necklace, in black and white.

Prof Peter Schmidt

“Relevium’s approach to osteoarthritis pain has the potential to revolutionize how we as clinicians treat this disabling condition”

Stanford Health Care logo with a shield emblem
Black and white portrait of a man with short dark hair, a beard, wearing a white shirt and dark tie.